Recent developments in veterinary vaccinology

Veterinary Journal

Volumn 170, Issue 3, 2005, Pages 289-299

  Shams, Homayoun ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Vaccine development; Vaccinology; Veterinary vaccines

Indexed keywords

BCG VACCINE; DNA VACCINE; GONADORELIN; HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HAEMOPHILUS VACCINE; HERPES VACCINE; IMMUNOLOGICAL ADJUVANT; LIVE VACCINE; MALARIA VACCINE; OVALBUMIN; POLYSACCHARIDE VACCINE; PSEUDORABIES VACCINE; RECOMBINANT PROTEIN; SALMONELLOSIS VACCINE; SUBUNIT VACCINE; SYNTHETIC PEPTIDE; TETANUS TOXOID; VACCINE; VIRUS VACCINE; VIRUS VECTOR;

ANIMAL DISEASE; ANIMAL HEALTH; CATTLE DISEASE; CELLULAR IMMUNITY; DRUG CONJUGATION; DRUG DESIGN; DRUG POTENCY; DRUG SAFETY; DRUG SYNTHESIS; HOST CELL; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INFECTION PREVENTION; LYMPHOCYTE FUNCTION; MALARIA; NONHUMAN; PNEUMONIA; PSEUDORABIES; REVIEW; TRANSGENIC PLANT; TUBERCULOSIS; VACCINATION; VETERINARY MEDICINE; VIRUS INFECTION;

ANIMALIA; BOS TAURUS; HAEMOPHILUS; HAEMOPHILUS INFLUENZAE SEROTYPE B; HERPES;

EID: 27844473353     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2004.07.004     Document Type: Article

References (93)

1. Public health service recommendations for the use of vaccines manufactured with bovine-derived materials. Morbidity and Mortality Weekly Report 2000 49, 1137-1138.
2. S.T. Anderson B.M. Bindon M.A. Hillard T. O'Shea Increased ovulation rate in Merino ewes immunized against small synthetic peptide fragments of the inhibin α subunit Reproduction, Fertility and Development 10 1998 421-431
3. F.E. Andre Vaccinology: Past achievements, present roadblocks and future promises Vaccine 21 2003 593-595
4. L.A. Babiuk S. van Drunen Littel-van den Hurk B.I. Loehr R. Uwiera Veterinary applications of DNA vaccines Developmental Biology 104 2000 73-81
5. L.A. Babiuk R. Pontarollo S. Babiuk B. Loehr S. van Drunen Littel-van den Hurk Induction of immune responses by DNA vaccines in large animals Vaccine 21 2003 649-658
6. R.G. Barletta R.O. Donis O. Chacon H. Shams J.D. Cirillo Vaccines against intracellular pathogens Sub-cellular Biochemistry 33 2000 559-599
7. A.D. Barrett Current status of flavivirus vaccines Annals of New York Academy of Science 951 2001 262-271
8. M.A. Behr BCG-different strains, different vaccines? The Lancet Infectious Diseases 2 2002 86-92
9. E.B. Belknap L.M. Walters C. Kelling V.K. Ayers J. Norris J. McMillen C. Hayhow M. Cochran D.N. Reddy J. Wright J.K. Collins Immunogenicity and protective efficacy of a gE, gG and US2 gene-deleted bovine herpesvirus-1 (BHV-1) vaccine Vaccine 17 1999 2297-2305
10. C.A. Bona S. Casares T.D. Brumeanu Towards development of T-cell vaccines Immunology Today 19 1998 126-133
11. T.L. Bowersock S. Martin Vaccine delivery to animals Advanced Drug Delivery Reviews 38 1999 167-194
12. T.E. Carpenter Evaluation of effectiveness of a vaccination programme against an infectious disease at the population level American Journal of Veterinary Research 62 2001 202-205
13. G. Chappuis Neonatal immunity and immunisation in early age: Lessons from veterinary medicine Vaccine 16 1998 1468-1472
14. S.N. Chatfield C.J. Dorman C. Hayward G. Dougan Role of ompR-dependent genes in Salmonella typhimurium virulence: Mutants deficient in both ompC and ompF are attenuated in vivo Infection and Immunity 59 1991 449-452
15. L. Chedid F. Audibert M. Jolivet Role of muramyl peptides for the enhancement of synthetic vaccines Developments in Biological Standardization 63 1986 133-140
16. M. Chengalvala M.D. Lubeck A.R. Davis S. Mizutani K. Molnar-Kimber J. Morin P.P. Hung Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs Vaccine 9 1991 485-490
17. S.I. Chowdhury C.S. Ross B.J. Lee V. Hall H.J. Chu Construction and characterization of a glycoprotein E gene-deleted bovine herpesvirus type 1 recombinant American Journal of Veterinary Research 60 1999 227-232
18. B.T. Cookson L.A. Cummings S.L. Rassoulian Barrett Bacterial antigens elicit T cell responses via adaptive and transitional immune recognition Current Opinion in Microbiology 4 2001 267-273
19. G.L. Cooper R.A. Nicholas G.A. Cullen C.E. Hormaeche Vaccination of chickens with a Salmonella enteritidis aroA live oral Salmonella vaccine Microbial Pathogenesis 9 1990 255-265
20. R. Curtiss III S.M. Kelly S.A. Tinge C.O. Tacket M.M. Levine J. Srinivasan M. Koopman Recombinant Salmonella vectors in vaccine development Developments in Biological Standardization 82 1994 23-33
21. D.L. Dadley-Moore M.W. Lightowlers J.S. Rothel D.C. Jackson Synthetic peptide antigens induce antibodies to Taenia ovis oncospheres Vaccine 17 1999 1506-1515
22. X.N. Dong K. Wei Z.Q. Liu Y.H. Chen Candidate peptide vaccine induced protection against classical swine fever virus Vaccine 21 2002 167-173
23. K.F. Dowsett U. Tshewang L.M. Knott A.E. Jackson T.E. Trigg Immunocastration of colts and immunospaying of fillies Immunology and Cell Biology 71 Pt 5 1993 501-508
24. S.J. Dunachie A.V. Hill Prime-boost strategies for malaria vaccine development Journal of Experimental Biology 206 2003 3771-3779
25. B.W. Fenwick B.I. Osburn Vaccine potential of Haemophilus pleuropneumoniae oligosaccharide-tetanus toxoid conjugates Infection and Immunity 54 1986 583-586
26. E.F. Flores F.A. Osorio E.L. Zanella S. Kit M. Kit Efficacy of a deletion mutant bovine herpesvirus-1 (BHV-1) vaccine that allows serologic differentiation of vaccinated from naturally infected animals Journal of Veterinary Diagnostic Investigation 5 1993 534-540
27. U. Fluckiger K.F. Jones V.A. Fischetti Immunoglobulins to group A streptococcal surface molecules decrease adherence to and invasion of human pharyngeal cells Infection and Immunity 66 1998 974-979
28. J.C. Frantz P.K. Bhatnagar A.L. Brown L.K. Garrett J.L. Hughes Investigation of synthetic Escherichia coli heat-stable enterotoxin as an immunogen for swine and cattle Infection and Immunity 55 1987 1077-1084
29. J.E. Galan R. Curtiss III Virulence and vaccine potential of phoP mutants of Salmonella typhimurium Microbial Pathogenesis 6 1989 433-443
30. R.N. Germain Modern concepts in immune recognition and lymphocyte activation. Relevance for the development of useful vaccines International Journal of Technology Assessment in Health Care 10 1994 81-92
31. R.N. Germain The biochemistry and cell biology of antigen presentation by MHC class I and class II molecules. Implications for development of combination vaccines Annals of New York Academy of Science 754 1995 114-125
32. R. Germanier E. Furer Characteristics of the attenuated oral Developments in Biological Standardization 53 1983 3-7
33. L.T. Glickman Weighing the risks and benefits of vaccination Advances in Veterinary Medicine 41 1999 701-713
34. P.L. Goossens C. Montixi M.F. Saron M. Rodriguez F. Zavala G. Milon Listeria monocytogenes: A live vector able to deliver heterologous protein within the cytosol and to drive a CD8 dependent T-cell response Biologicals 23 1995 135-143
35. C.M. Hardy J.F. ten Have K.J. Mobbs L.A. Hinds Assessment of the immunocontraceptive effect of a zona pellucida 3 peptide antigen in wild mice Reproduction, Fertility and Development 14 2002 151-155
36. L.M. Henderson J.B. Katz G.A. Erickson J.E. Mayfield In vivo and in vitro genetic recombination between conventional and gene-deleted vaccine strains of pseudorabies virus American Journal of Veterinary Research 51 1990 1656-1662
37. S.K. Hoiseth B.A. Stocker Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines Nature 291 1981 238-239
38. D.M. Hone A.M. Harris S. Chatfield G. Dougan M.M. Levine Construction of genetically defined double aro mutants of Salmonella typhi Vaccine 9 1991 810-816
39. R.W. Hostoffer I. Krukovets M. Berger Enhancement by tumor necrosis factor-alpha of Fc alpha receptor expression and IgA-mediated superoxide generation and killing of Pseudomonas aeruginosa by polymorphonuclear leukocytes The Journal of Infectious Diseases 170 1994 82-87
40. P.W. Jones G. Dougan C. Hayward N. Mackensie P. Collins S.N. Chatfield Oral vaccination of calves against experimental salmonellosis using a double aro mutant of Salmonella typhimurium Vaccine 9 1991 29-34
41. M.J. Kaashoek F.A. Rijsewijk R.C. Ruuls G.M. Keil E. Thiry P.P. Pastoret J.T. van Oirschot Virulence, immunogenicity and reactivation of bovine herpesvirus 1 mutants with a deletion in the gC, gG, gI, gE, or in both the gI and gE gene Vaccine 16 1998 802-809
42. S.H. Kaufmann J. Hess Impact of intracellular location of and antigen display by intracellular bacteria: Implications for vaccine development Immunology Letters 65 1999 81-84
43. D.T. Kim D.J. Mitchell D.G. Brockstedt L. Fong G.P. Nolan C.G. Fathman E.G. Engleman J.B. Rothbard Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide Journal of Immunology 159 1997 1666-1668
44. S. Kit Genetically engineered vaccines for control of Aujeszky's disease (pseudorabies) Vaccine 8 1990 420-424
45. R.S. Koff Immunogenicity of hepatitis B vaccines: Implications of immune memory Vaccine 20 2002 3695-3701
46. A. Ladd Y.Y. Tsong J. Lok R.B. Thau Active immunisation against LHRH: I. Effects of conjugation site and dose American Journal of Reproductive Immunology 22 1990 56-63
47. J.P. Langeveld S. Kamstrup A. Uttenthal B. Strandbygaard C. Vela K. Dalsgaard N.J. Beekman R.H. Meloen J.I. Casal Full protection in mink against mink enteritis virus with new generation canine parvovirus vaccines based on synthetic peptide or recombinant protein Vaccine 13 1995 1033-1037
48. J.R. Lehman R.M. Weigel A.M. Siegel L.G. Herr A.C. Taft W.F. Hall Progress after one year of a pseudorabies eradication programme for large swine herds Journal of American Veterinary Medical Association 203 1993 118-121
49. M.M. Levine H.L. DuPont R.B. Hornick M.J. Snyder W. Woodward R.H. Gilman J.P. Libonati Attenuated, streptomycin-dependent Salmonella typhi oral vaccine: Potential deleterious effects of lyophilization The Journal of Infectious Diseases 133 1976 424-429
50. A.H. Lucas D.C. Reason Polysaccharide vaccines as probes of antibody repertoires in man Immunological Reviews 171 1999 89-104
51. R.K. Maes M.D. Sussman A. Vilnis B.J. Thacker Recent developments in latency and recombination of Aujeszky's disease (pseudorabies) virus Veterinary Microbiology 55 1997 13-27
52. H. McShane Prime-boost immunization strategies for infectious diseases Current Opinion in Molecular Therapeutics 4 2002 23-27
53. T.P. Monath Prospects for development of a vaccine against the West Nile virus Annals of New York Academy of Science 951 2001 1-12
54. M. Moos Models of risk assessments for biologicals or related products in the European Union Revue Scientifique et Technique 14 1995 1009-1020
55. D.G. Morris M.G. McDermott M.G. Diskin C.A. Morrison P.J. Swift J.M. Sreenan Effect of immunisation against synthetic peptide sequences of bovine inhibin α-subunit on ovulation rate and twin-calving rate in heifers Journal of Reproduction and Fertility 97 1993 255-261
56. D.M. Mosser Receptors on phagocytic cells involved in microbial recognition Immunology Series 60 1994 99-114
57. E.H. Moylett I.C. Hanson 29 Immunisation The Journal of Allergy and Clinical Immunology 111 2003 754-765
58. C.W. Olsen A review of feline infectious peritonitis virus: Molecular biology, immunopathogenesis, clinical aspects, and vaccination Veterinary Microbiology 36 1993 1-37
59. P.P. Pastoret Veterinary vaccinology Comptes Rendus de l'Académie des Sciences - Series III - Sciences de la Vie 322 1999 967-972
60. L. Prevec J.B. Campbell B.S. Christie L. Belbeck F.L. Graham A recombinant human adenovirus vaccine against rabies The Journal of Infectious Diseases 161 1990 27-30
61. J. Reimann R. Schirmbeck Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation Immunological Reviews 172 1999 131-152
62. V. Robbe-Saule C. Coynault F. Norel The live oral typhoid vaccine Ty21a is a rpoS mutant and is susceptible to various environmental stresses FEMS Microbiology Letters 126 1995 171-176
63. H.L. Robinson C.A. Torres DNA vaccines Seminars in Immunology 9 1997 271-283
64. H. Russmann H. Shams F. Poblete Y. Fu J.E. Galan R.O. Donis Delivery of epitopes by the Salmonella type III secretion system for vaccine development Science 281 1998 565-568
65. O.C. Schunicht C.W. Booker G.K. Jim P.T. Guichon B.K. Wildman B.W. Hill Comparison of a multivalent viral vaccine programme versus a univalent viral vaccine programme on animal health, feedlot performance, and carcass characteristics of feedlot calves The Canadian Veterinary Journal 44 2003 43-50
66. D.C. Sellon Equine infectious anaemia. The Veterinary Clinics of North America Equine Practice 9 1993 321-336
67. H. Shams F. Poblete H. Russmann J.E. Galan R.O. Donis Induction of specific CD8+ memory T cells and long lasting protection following immunisation with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope Vaccine 20 2001 577-585
68. M. Singh D.T. O'Hagen Recent advances in veterinary vaccine adjuvants International Journal for Parasitology 33 2003 469-478
69. M.A. Skinner B.M. Buddle D.N. Wedlock D. Keen G.W. de Lisle R.E. Tascon J.C. Ferraz D.B. Lowrie P.J. Cockle H.M. Vordermeier R.G. Hewinson A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis Infection and Immunity 71 2003 4901-4907
70. N. Srivastava R. Santhanam P. Sheela S. Mukund S.S. Thakral B.S. Malik S.K. Gupta Evaluation of the immunocontraceptive potential of Escherichia coli-expressed recombinant dog ZP2 and ZP3 in a homologous animal model Reproduction 123 2002 847-857
71. B.A. Stocker S.K. Hoiseth B.P. Smith Aromatic-dependent "Salmonella sp." as live vaccine in mice and calves Developments in Biological Standardization 53 1983 47-54
72. C.K. Stover V.F. de la Cruz T.R. Fuerst J.E. Burlein L.A. Benson L.T. Bennett G.P. Bansal J.F. Young M.H. Lee G.F. Hatfull New use of BCG for recombinant vaccines Nature 351 1991 456-460
73. S.J. Streatfield J.A. Howard Plant-based vaccines International Journal for Parasitology 33 2003 479-493
74. G. Sutter B. Moss Non-replicating vaccinia vector efficiently expresses recombinant genes Proceedings of the National Academy of Sciences of the United States of America 89 1992 10847-10851
75. S.L. Swenson J. McMillen H.T. Hill Diagnostic compatibility of a thymidine kinase, inverted repeat, gI, and gpX modified live gene-deleted PRV vaccine with three differential ELISAs Journal of Veterinary Diagnostic Investigation 5 1993 347-350
76. S.L. Swenson J. McMillen H.T. Hill Evaluation of the safety and efficacy of a thymidine kinase, inverted repeat, gI, and gpX gene-deleted pseudorabies vaccine Journal of Veterinary Diagnostic Investigation 5 1993 341-346
77. C.O. Tacket D.M. Hone R. Curtiss III S.M. Kelly G. Losonsky L. Guers A.M. Harris R. Edelman M.M. Levine Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers Infection and Immunity 60 1992 536-541
78. C.O. Tacket D.M. Hone G.A. Losonsky L. Guers R. Edelman M.M. Levine Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain Vaccine 10 1992 443-446
79. H. Takahashi Antigen presentation in vaccine development Comparative Immunology, Microbiology and Infectious Diseases 26 2003 309-328
80. C. Terpstra A.H. Kroese Potency control of modified live viral vaccines for veterinary use Vaccine 14 1996 13-18
81. C. Terpstra A.H. Kroese Potency control of modified live viral vaccines for veterinary use Vaccine 14 1996 570-575
82. R.B. Tesh J. Arroyo A.P. Travassos Da Rosa H. Guzman S.Y. Xiao T.P. Monath Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model Emerging Infectious Diseases 8 2002 1392-1397
83. J. van Bergen F. Ossendorp R. Jordens A.M. Mommaas J.W. Drijfhout F. Koning Get into the groove! Targeting antigens to MHC class II Immunological Reviews 172 1999 87-96
84. J.T. van Oirschot Diva vaccines that reduce virus transmission Journal of Biotechnology 73 1999 195-205
85. J.T. van Oirschot Present and future of veterinary viral vaccinology: A review The Veterinary Quarterly 23 2001 100-108
86. H.M. Vordermeier D.B. Lowrie R.G. Hewinson Improved immunogenicity of DNA vaccination with mycobacterial HSP65 against bovine tuberculosis by protein boosting Veterinary Microbiology 93 2003 349-359
87. P.D. Walker Bacterial vaccines: Old and new, veterinary and medical Vaccine 10 1992 977-990
88. H. Warzecha H.S. Mason Benefits and risks of antibody and vaccine production in transgenic plants Journal of Plant Physiology 160 2003 755-764
89. M. Wegener L. Bruckner K. Cubetaler The establishment of endotoxin limits which satisfy animal welfare considerations in the testing of porcine vaccines ALTEX: Alternativen zu Tierexperimenten 15 1998 65-67
90. C.A. Whetstone J.M. Miller B.S. Seal L.J. Bello W.C. Lawrence Latency and reactivation of a thymidine kinase-negative bovine herpesvirus 1 deletion mutant Archives of Virology 122 1992 207-214
91. D.W. White R.L. Wilson J.T. Harty CD8+ T cells in intracellular bacterial infections of mice Research in Immunology 147 1996 519-524
92. N. Yuasa I. Yoshida T. Taniguchi Isolation of a reticuloendotheliosis virus from chickens inoculated with Marek's disease vaccine National Institute of Animal Health Quarterly (Tokyo) 16 1976 141-151
93. X.Y. Zeng J.A. Turkstra A. Tsigos R.H. Meloen X.Y. Liu F.Q. Chen W.M. Schaaper H.B. Oonk D.Z. Guo D.F. van de Wiel Effects of active immunisation against GnRH on serum LH, inhibin A, sexual development and growth rate in Chinese female pigs Theriogenology 58 2002 1315-1326